Clinical Trial Update: Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Herombopag to prevent radio-chemotherapy induced thrombocytopenia in cervical cancer; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Thrombocytopenia

Drugs mentioned

• Herombopag (herombopag)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Thrombopenia, Cervical Cancer | Phase 2 | Status: NOT_YET_RECRUITING